Real World Outcomes for Patients with HCC Receiving Lenvatinib After IO

preview_player
Показать описание
Amit Mahipal, MD, University Hospitals Seidman Cancer Center, and Richard S. Finn, MD, University of California, Los Angeles, discuss a recent study on real-world outcomes for patients with advanced hepatocellular carcinoma receiving lenvatinib following immunotherapy.
  1. GI Oncology Now
Рекомендации по теме
Real-world Outcomes for 0:14:34

Real-world Outcomes for Patients Treated with Ide-Cel after having Received a BCMA-targeted therapy

Dr. Leslie on 0:01:40

Dr. Leslie on Real-World Outcomes of Patients With CLL Treated With Acalabrutinib

The real-world outcomes 0:01:45

The real-world outcomes of patients with CLL who discontinue BTKi therapy

Real-world outcomes of 0:01:18

Real-world outcomes of patients with mantle cell lymphoma

Real-world outcomes of 0:01:24

Real-world outcomes of patients with BV and anti-PD-1 intolerant cHL: the impact of alloSCT & CA...

Real World Outcomes 0:06:38

Real World Outcomes for Patients with HCC Receiving Lenvatinib After IO

Real-world outcomes of 0:01:22

Real-world outcomes of patients with MF treated with fedratinib post-ruxolitinib discontinuation

Analysis of real-world 0:02:18

Analysis of real-world outcomes in patients with B-ALL receiving tisagenlecleucel

ABSOLUTE BEST Way 0:01:50

ABSOLUTE BEST Way to Make Data Driven Decisions in 2025

Thomas Ciulla: Real-World 0:02:06

Thomas Ciulla: Real-World Outcomes for DME Patients

Real-world outcomes of 0:01:47

Real-world outcomes of tandem transplantation in patients with newly diagnosed multiple myeloma

Investigating real-world outcomes 0:05:36

Investigating real-world outcomes of patients with R/R LBCL after CD19 CAR-T cell therapy

Real-world outcomes of 0:04:13

Real-world outcomes of patients with R/R B-ALL treated with blinatumomab and inotuzumab ozogamicin

Real-world outcomes of 0:03:45

Real-world outcomes of brexu-cel in patients with R/R MCL

Real-world outcomes of 0:03:18

Real-world outcomes of patients with intrahepatic CCA treated with trans-arterial radioembolization

Real-world outcomes of 0:03:36

Real-world outcomes of IO & TKIs in mRCC

Impact of novel 0:02:50

Impact of novel therapies on real-world outcomes of patients with R/R MCL by ethnicity & TP53m

Assessing the real-world 0:00:57

Assessing the real-world outcomes and safety of belzutifan in patients with VHL associated tumors

Real-world outcomes of 0:03:23

Real-world outcomes of patients with transformed R/R DLBCL treated with CD19 CAR-T therapy

Real-world outcomes of 0:01:45

Real-world outcomes of mRCC in the current IO & TKI era

Real-world outcomes of 0:01:19

Real-world outcomes of liso-cel therapy in R/R DLBCL

The first analysis 0:01:12

The first analysis from the ECHOS study of real-world outcomes of docetaxel in patients with mCSPC

Brian Van Tine, 0:00:57

Brian Van Tine, MD, considers the role of real-world outcomes in the treatment of sarcoma

Using big data 0:14:09

Using big data to define and validate real world outcomes in Alzheimer’s disease, Dr. Martin Pan